Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,661 to 1,680 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD27 expression on Treg cells limits immune responses against tumors. | J Mol Med (Berl) | 2022 | 34423375 | PubTator, text mining | PubMed |
| Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies. | Acta Ophthalmol | 2022 | 34318583 | PubTator, text mining | PubMed |
| CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies. | Cell Mol Immunol | 2022 | 34282297 | PubTator, text mining | PubMed |
| Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF. | Cardiovasc Res | 2022 | 34264317 | PubTator, text mining | PubMed |
| Stepping forward in antibody-drug conjugate development. | Pharmacol Ther | 2022 | 34171334 | PubTator, text mining | PubMed |
| CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells. | Cancer Immunol Immunother | 2022 | 34037810 | PubTator, text mining | PubMed |
| Conditioning treatment with CD27 Ab enhances expansion and antitumor activity of adoptively transferred T cells in mice. | Cancer Immunol Immunother | 2022 | 34028568 | PubTator, text mining | PubMed |
| The antigen-binding moiety in the driver's seat of CARs. | Med Res Rev | 2022 | 34028069 | PubTator, text mining | PubMed |
| Engineered cells as glioblastoma therapeutics. | Cancer Gene Ther | 2022 | 33753869 | PubTator, text mining | PubMed |
| Formulation and Delivery Technologies for mRNA Vaccines. | Curr Top Microbiol Immunol | 2022 | 32483657 | PubTator, text mining | PubMed |
| DNA Methylation of CD70 Promoter in Juvenile Systemic Lupus Erythematosus. | Fetal Pediatr Pathol | 2022 | 32427516 | PubTator, text mining | PubMed |
| Tumor-associated macrophages, dendritic cells, and neutrophils: biological roles, crosstalk, and therapeutic relevance. | Med Rev (2021) | 2021 | 37724296 | PubTator, text mining | PubMed |
| The beginning of a new therapeutic era in acute myeloid leukemia. | EJHaem | 2021 | 35845213 | PubTator, text mining | PubMed |
| Is an Immunosuppressive Microenvironment a Characteristic of Both Intra- and Extraparenchymal Central Nervous Tumors? | Pathophysiology | 2021 | 35366268 | PubTator, text mining | PubMed |
| Single-Cell RNA-Seq Analysis Reveals Macrophage Involved in the Progression of Human Intervertebral Disc Degeneration. | Front Cell Dev Biol | 2021 | 35295968 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis. | Front Neurol | 2021 | 35281989 | PubTator, text mining | PubMed |
| Thymolipoma - the frontier between hamartoma and neoplasia? | Rom J Morphol Embryol | 2021 | 35263392 | PubTator, text mining | PubMed |
| Functions of RNF Family in the Tumor Microenvironment and Drugs Prediction in Grade II/III Gliomas. | Front Cell Dev Biol | 2021 | 35223862 | PubTator, text mining | PubMed |
| Multi-Level Computational Modeling of Anti-Cancer Dendritic Cell Vaccination Utilized to Select Molecular Targets for Therapy Optimization. | Front Cell Dev Biol | 2021 | 35186943 | PubTator, text mining | PubMed |
| Optimization of Donor Lymphocyte Infusion for AML Relapse After Allo-HCT in the Era of New Drugs and Cell Engineering. | Front Oncol | 2021 | 35155192 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=84